The diverse biological effects of polyinosinic-polycytidylic acid.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy; D002645:Chickens; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology; D005260:Female; D006801:Humans; D007106:Immune Sera; D007372:Interferons / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011070:Poly I-C / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D011119:Polynucleotides / Q000494:pharmacology*; D011247:Pregnancy; D012313:RNA / Q000494:pharmacology; D011817:Rabbits; D012756:Sheep; D013045:Species Specificity; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D014762:Viral Interference / Q000187:drug effects
D000970:Antineoplastic Agents; D007106:Immune Sera; D011119:Polynucleotides; D012313:RNA; D007372:Interferons; D011070:Poly I-C